Publications by authors named "Heather Wakelee"

100Publications

PD-1/PD-L1 Checkpoint Inhibitor Immunotherapy for Malignant Pleural Mesothelioma: Case Series and Literature Review.

Clin Lung Cancer 2020 May 22. Epub 2020 May 22.

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2020.05.012DOI Listing
May 2020

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.

Cancer Cell 2020 06 16;37(6):742-745. Epub 2020 May 16.

Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2020.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229923PMC
June 2020

A PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORS.

Cancer Treat Res Commun 2020 Apr 20;23:100174. Epub 2020 Apr 20.

Stanford University School of Medicine, Department of Internal Medicine, Division of Oncology, Stanford Cancer Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100174DOI Listing
April 2020

Adjuvant Chemotherapy.

Thorac Surg Clin 2020 May 2;30(2):179-185. Epub 2020 Mar 2.

Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thorsurg.2020.01.003DOI Listing
May 2020

Evaluating the Role of Targeted Therapy in Lung Cancer.

Authors:
Heather Wakelee

Oncology (Williston Park) 2019 Dec 12;33(12). Epub 2019 Dec 12.

View Article

Download full-text PDF

Source
December 2019

Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes".

Lung Cancer 2019 11 26;137:159-160. Epub 2019 Aug 26.

Stanford Cancer Institute, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.08.020DOI Listing
November 2019

Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer.

Lung Cancer 2019 08 3;134:42-45. Epub 2019 May 3.

Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.002DOI Listing
August 2019

Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes.

Lung Cancer 2019 07 15;133:144-150. Epub 2019 May 15.

Stanford Cancer Institute, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94304, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.015DOI Listing
July 2019

Role of Immunotherapy in Small Cell Lung Cancer, Thymic Epithelial Tumors, and Mesothelioma.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:543-552. Epub 2019 May 17.

4 Division of Oncology, Department of Medicine, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_237847DOI Listing
January 2019

Tumor Heterogeneity and Testing Discrepancy Confound ROS1 Detection in NSCLC.

J Thorac Oncol 2019 06 23;14(6):e111-e113. Epub 2019 Mar 23.

Department of Medical Oncology, Stanford Cancer Institute, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.03.011DOI Listing
June 2019

Increased Galectin-1 Expression in Thymic Epithelial Tumors.

Clin Lung Cancer 2019 05 21;20(3):e356-e361. Epub 2018 Dec 21.

Department of Radiation Oncology, Stanford University School of Medicine Stanford Cancer Institute, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.12.005DOI Listing
May 2019

Case closed: another prophylactic cranial irradiation trial for stage 3 non-small cell lung cancer fails to improve overall survival.

Ann Transl Med 2018 Dec;6(Suppl 2):S118

Department of Neurology, Stanford University School of Medicine, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.12.24DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330621PMC
December 2018

Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and Vietnam.

J Glob Oncol 2018 11;4:1-9

Kim-Son H. Nguyen, Palo Alto Medical Foundation, Mountain View; Henning Stehr, Li Zhou, Heather A. Wakelee, Maximilian Diehn, and Joel W. Neal, Stanford University School of Medicine, Stanford; Anh-Hoa Nguyen, AK Research Group, Redwood City, CA; Pham Nhu Hiep, Nguyen Van Cau, Hue Central Hospital; Phan Canh Duy, Hue University School of Medicine and Pharmacy, Hue, Vietnam; and Richard Thorp, BioreclamationIVT, Chestertown, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.18.00086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818292PMC
November 2018

Lengthy Progression-Free Survival and Intracranial Activity of Cabozantinib in Patients with Crizotinib and Ceritinib-Resistant ROS1-Positive Non-Small Cell Lung Cancer.

J Thorac Oncol 2019 02 11;14(2):e21-e24. Epub 2018 Sep 11.

Department of Medical Oncology, Stanford Cancer Institute, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.08.2030DOI Listing
February 2019

Caution Needed for Analyzing the Risks of Second Cancers.

J Thorac Oncol 2018 09;13(9):e172-e173

Department of Medicine, Stanford University School of Medicine, Stanford, California; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.018DOI Listing
September 2018

Osimertinib for -Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study.

Oncologist 2019 06 20;24(6):836-843. Epub 2018 Aug 20.

Division of Oncology, Stanford University School of Medicine, Stanford, California, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656518PMC
June 2019

Perspectives on Acquired Resistance to PD-1 Axis Inhibitors in Patients with Non-Small Cell Lung Cancer.

J Thorac Oncol 2018 06;13(6):741-744

Stanford Cancer Institute, Stanford University, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183053
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.04.008DOI Listing
June 2018

Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.

Clin Lung Cancer 2018 09 19;19(5):e581-e588. Epub 2018 Apr 19.

Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.04.003DOI Listing
September 2018

Circulating tumor DNA testing in advanced non-small cell lung cancer.

Lung Cancer 2018 05 2;119:42-47. Epub 2018 Mar 2.

Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.02.019DOI Listing
May 2018

Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS.

Curr Treat Options Oncol 2017 11 16;18(12):71. Epub 2017 Nov 16.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, CC-2233, 875 Blake Wilbur Drive, Palo Alto, CA, 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-017-0513-xDOI Listing
November 2017

Does plasma-based molecular testing have a role in the routine care of lung cancer?

Authors:
Heather Wakelee

Clin Adv Hematol Oncol 2017 Aug;15(8):599-601

Stanford University Medical Center, Stanford, California.

View Article

Download full-text PDF

Source
August 2017

The J-ALEX trial-is frontline alectinib a new standard of care?

J Thorac Dis 2017 Aug;9(8):2242-2245

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.06.134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594119PMC
August 2017

Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.

J Thorac Cardiovasc Surg 2017 12 1;154(6):2092-2099.e2. Epub 2017 Aug 1.

Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Stanford, Calif; Veterans Affairs Palo Alto Health Care System, Palo Alto, Calif. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2017.07.034DOI Listing
December 2017

Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer.

Radiother Oncol 2017 11 19;125(2):338-343. Epub 2017 Aug 19.

Department of Radiation Oncology, Stanford University, USA; Stanford Cancer Institute, Stanford University School of Medicine, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2017.08.007DOI Listing
November 2017

Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.

Int J Radiat Oncol Biol Phys 2017 09 6;99(1):16-21. Epub 2017 May 6.

Department of Radiation Oncology, Stanford University, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.04.041DOI Listing
September 2017

Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women's Health Initiative.

Lung Cancer 2017 08 8;110:42-47. Epub 2017 Jun 8.

Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY 14214, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.06.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541890PMC
August 2017

Risk Stratification for Second Primary Lung Cancer.

J Clin Oncol 2017 Sep 23;35(25):2893-2899. Epub 2017 Jun 23.

Summer S. Han, Sylvia K. Plevritis, and Heather A. Wakelee, Stanford University School of Medicine; Summer S. Han, Sylvia K. Plevritis, Scarlett L. Gomez, Iona Cheng, and Heather A. Wakelee, Stanford Cancer Institute; Heather A. Wakelee and Gabriel A. Rivera, Stanford University Department of Medicine, Division of Oncology, Stanford; Gabriel A. Rivera, Kaiser Permanente Fresno Medical Center, Fresno; Scarlett L. Gomez and Iona Cheng, Cancer Prevention Institute of California, Fremont, CA; and Martin C. Tammemägi, Brock University, St Catharines, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.4203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946715PMC
September 2017

A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer.

Lung Cancer 2017 06 29;108:173-182. Epub 2017 Mar 29.

Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr, MC 5847, Stanford, CA 94305, United States; Stanford Cancer Institute, 265 Campus Drive, Ste G2103, Stanford, CA 94305, United States; Institute for Stem Cell Biology and Regenerative Medicine, 265 Campus Drive, 3rd Floor Stanford, CA 94305, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.03.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502824PMC
June 2017

Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years.

Lung Cancer 2017 06 30;108:140-149. Epub 2017 Mar 30.

Cancer Prevention Institute of California, 2201 Walnut Avenue, Fremont, CA, 94538, USA; Stanford Cancer Institute, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.03.014DOI Listing
June 2017

Heather Wakelee on the Role of Checkpoint Inhibitors in Advanced Lung Cancer.

Authors:
Heather Wakelee

Oncology (Williston Park) 2017 06;31(6):440, 442

View Article

Download full-text PDF

Source
June 2017

Keynote Address: -As Physician Becomes Patient.

J Natl Compr Canc Netw 2017 05;15(5S):696-698

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.0076DOI Listing
May 2017

Targeting -Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.

Oncologist 2017 07 9;22(7):786-796. Epub 2017 May 9.

Stanford University Medical Center, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507646PMC
July 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

ERBB2-Mutated Metastatic Non-Small Cell Lung Cancer: Response and Resistance to Targeted Therapies.

J Thorac Oncol 2017 05 4;12(5):833-842. Epub 2017 Feb 4.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.01.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402884PMC
May 2017

Elusive Target of Angiogenesis in Small-Cell Lung Cancer.

J Clin Oncol 2017 04 6;35(12):1269-1271. Epub 2017 Feb 6.

Joel W. Neal and Heather A. Wakelee, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.6084DOI Listing
April 2017

Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung Cancer.

Hematol Oncol Clin North Am 2017 02;31(1):31-44

Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, 875 Blake Wilbur Drive, Room 2233, Stanford, CA 94305-5826, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2016.08.011DOI Listing
February 2017

Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?

Curr Atheroscler Rep 2016 Dec;18(12):72

Department of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11883-016-0625-yDOI Listing
December 2016

Pretreatment biopsy for thymic epithelial tumors-does histology subtype matter for treatment strategy?

J Thorac Dis 2016 Aug;8(8):1895-900

Department of Medicine (Oncology), Stanford University/Stanford Cancer Institute, Stanford, CA, USA ;

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/8340/7841
Publisher Site
http://dx.doi.org/10.21037/jtd.2016.06.77DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999713PMC
August 2016

Resistance to Therapy.

Cancer Treat Res 2016;170:183-202

Stanford University, Stanford Cancer Institute, 875 Blake Wilbur Drive, Stanford, CA, 94305-5826, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-40389-2_9DOI Listing
June 2017

Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.

Clin Lung Cancer 2017 01 27;18(1):5-12. Epub 2016 Jun 27.

Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.06.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361177PMC
January 2017

Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.

J Clin Oncol 2016 08 18;34(24):2866-73. Epub 2016 Jul 18.

Lucio Crinò, University Medical School of Perugia, Azienda Ospedale Perugia, Perugia; Filippo De Marinis, European Institute of Oncology, Milan; Giorgio Scagliotti, University of Torino, Torino, Italy; Myung-Ju Ahn, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea; Harry J.M. Groen, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Heather Wakelee, Stanford University Medical Center, Stanford, CA; Toyoaki Hida, Aichi Cancer Center, Nagoya; Makoto Nishio, Japanese Foundation for Cancer Research, Tokyo, Japan; Tony Mok, Chinese University of Hong Kong, Shatin, China; David Spigel, Sarah Cannon Research Institute, Nashville, TN; Enriqueta Felip, Vall d'Hebron University, Barcelona, Spain; Fabrice Branle and Massimiliano Quadrigli, Novartis Pharma AG, Basel, Switzerland; Chetachi Emeremni and Jie Zhang, Novartis Pharma, East Hanover, NJ; and Alice T. Shaw, Massachusetts General Hospital, Boston MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.65.5936
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.65.5936DOI Listing
August 2016

Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.

Clin Ther 2016 Jul 29;38(7):1567-76. Epub 2016 Jun 29.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2016.06.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985173PMC
July 2016

Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directions.

Expert Opin Pharmacother 2016 4;17(7):989-93. Epub 2016 Apr 4.

b Department of Medicine, Division of Oncology , Stanford University School of Medicine , Stanford , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2016.1162786DOI Listing
September 2016

Lung Cancer Survival Among Chinese Americans, 2000 to 2010.

J Glob Oncol 2016 Feb 20;2(1):30-38. Epub 2016 Jan 20.

, , , and , Cancer Prevention Institute of California, Fremont; and , Stanford School of Medicine; , , , , and , Stanford Cancer Institute, Stanford; and , , and , Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2015.000539DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497738PMC
February 2016

Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.

Clin Lung Cancer 2016 Mar 18;17(2):e17-21. Epub 2015 Dec 18.

Division of Medical Oncology, Stanford Hospital and Clinics, Stanford, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2015.12.001DOI Listing
March 2016

Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy.

J Cutan Pathol 2016 Apr 10;43(4):339-46. Epub 2016 Feb 10.

Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12666DOI Listing
April 2016